−0.46 NGN
−2.87 B NGN
2.21 B NGN
3.16 B
About NEIMETH INTERNATIONAL PHARMACEUTICALS PLC
Sector
CEO
Valentine C. Okelu
Headquarters
Ikeja
Website
Founded
1957
ISIN
NGNEIMETH001
FIGI
BBG000P1M790
Neimeth International Pharmaceuticals Plc engages in the manufacture and marketing of pharmaceuticals, animal health products, and general health products. It operates through the Pharmaceuticals Product Group and Animal Health Product Group segments. The Pharmaceuticals Product Group segment includes the marketing and sale of the firm's branded products, and the consumer product group. The Animal Health Product Group segment covers the marketing and sale of poultry and large animal range of anthelmintic, as well as production enhancing medicaments. The company was founded on August 13, 1957 and is headquartered in Ikeja, Nigeria.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NEIMETH is 1.92 NGN — it has increased by 1.05% in the past 24 hours. Watch NEIMETH INTERNATIONAL PHARMACEUTICALS PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSENG exchange NEIMETH INTERNATIONAL PHARMACEUTICALS PLC stocks are traded under the ticker NEIMETH.
NEIMETH stock has risen by 6.08% compared to the previous week, the month change is a −3.03% fall, over the last year NEIMETH INTERNATIONAL PHARMACEUTICALS PLC has showed a 16.36% increase.
NEIMETH reached its all-time high on Nov 16, 2020 with the price of 2.91 NGN, and its all-time low was 0.35 NGN and was reached on Jul 26, 2018. View more price dynamics on NEIMETH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NEIMETH stock is 1.04% volatile and has beta coefficient of 0.13. Track NEIMETH INTERNATIONAL PHARMACEUTICALS PLC stock price on the chart and check out the list of the most volatile stocks — is NEIMETH INTERNATIONAL PHARMACEUTICALS PLC there?
Today NEIMETH INTERNATIONAL PHARMACEUTICALS PLC has the market capitalization of 8.12 B, it has increased by 1.57% over the last week.
Yes, you can track NEIMETH INTERNATIONAL PHARMACEUTICALS PLC financials in yearly and quarterly reports right on TradingView.
NEIMETH net income for the last quarter is 112.26 M NGN, while the quarter before that showed 120.57 M NGN of net income which accounts for −6.89% change. Track more NEIMETH INTERNATIONAL PHARMACEUTICALS PLC financial stats to get the full picture.
As of Nov 11, 2024, the company has 202.00 employees. See our rating of the largest employees — is NEIMETH INTERNATIONAL PHARMACEUTICALS PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEIMETH INTERNATIONAL PHARMACEUTICALS PLC EBITDA is 272.21 M NGN, and current EBITDA margin is −35.04%. See more stats in NEIMETH INTERNATIONAL PHARMACEUTICALS PLC financial statements.
Like other stocks, NEIMETH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEIMETH INTERNATIONAL PHARMACEUTICALS PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEIMETH INTERNATIONAL PHARMACEUTICALS PLC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEIMETH INTERNATIONAL PHARMACEUTICALS PLC stock shows the buy signal. See more of NEIMETH INTERNATIONAL PHARMACEUTICALS PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.